Valuation : Divi's Laboratories Limited

Market Cap 2,473B 26.15B 22.49B 21.15B 19.31B 36.11B 36.22B 251B 96.93B 1,266B 98.19B 96.05B 4,034B P/E 2027 *
75.8x
P/E 2028 * 62.9x
Enterprise Value 2,438B 25.78B 22.17B 20.85B 19.03B 35.6B 35.71B 247B 95.56B 1,248B 96.8B 94.69B 3,977B EV / Sales 2027 *
19.4x
EV / Sales 2028 * 16.2x
Free-Float
48.01%
Yield 2027 *
0.38%
Yield 2028 * 0.42%
1 day+2.36%
1 week+0.82%
Current month-1.61%
1 month+11.57%
3 months+40.65%
6 months+47.18%
Current year+45.72%
1 week 9,087
Extreme 9087
9,315
1 month 8,258.5
Extreme 8258.5
9,467
Current year 5,647.5
Extreme 5647.5
9,467
1 year 5,636.5
Extreme 5636.5
9,467
3 years 3,295.3
Extreme 3295.3
9,467
5 years 2,730
Extreme 2730
9,467
10 years 532.65
Extreme 532.65
9,467
Manager TitleAgeSince
Chief Executive Officer 75 26/11/2009
Chief Executive Officer 48 04/01/2020
Director of Finance/CFO 65 01/08/2025
Director TitleAgeSince
Director/Board Member 48 26/11/2009
Chairman 75 26/11/2009
Director/Board Member 68 01/10/1994
Date Insider Type Main position Quantity % Market Cap. Importance
26/3/25 Sell

Executive/Senior Manager

25,000 0.0094%
15/3/25 Sell 300 0.0001%
17/2/25 Sell 500 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
+2.36%+0.82%+55.02%+151.22% 25.59B
-0.88%-2.15%+58.05%+105.26% 1,024B
-1.15%+2.68%+54.25%+74.19% 663B
-1.44%+0.38%+20.65%+76.13% 453B
-0.95%-1.42%+28.96%+40.10% 352B
-3.18%+1.39%+20.66%+43.86% 304B
+0.30%+0.60%-0.40%+13.54% 252B
-1.55%+1.11%+54.15%+75.59% 236B
+0.02%+1.17%-14.59%-54.96% 206B
-0.15%+3.65%+31.24%+103.39% 187B
Average -0.66%+0.99%+30.80%+62.83% 370.4B
Weighted average by Cap. -1.05%+0.60%+37.33%+68.09%

Financials

2027 *2028 *
Net sales 126B 1.33B 1.14B 1.08B 982M 1.84B 1.84B 12.75B 4.93B 64.4B 4.99B 4.88B 205B 150B 1.59B 1.36B 1.28B 1.17B 2.19B 2.2B 15.2B 5.88B 76.77B 5.95B 5.82B 245B
Net income 32.65B 345M 297M 279M 255M 477M 478M 3.31B 1.28B 16.72B 1.3B 1.27B 53.26B 39.42B 417M 358M 337M 308M 576M 577M 4B 1.55B 20.19B 1.57B 1.53B 64.3B
Net Debt -35B -370M -318M -299M -273M -511M -513M -3.55B -1.37B -17.92B -1.39B -1.36B -57.09B -44.85B -474M -408M -384M -350M -655M -657M -4.55B -1.76B -22.97B -1.78B -1.74B -73.16B
Logo Divi's Laboratories Limited
Divi's Laboratories Limited is specialized in the development and manufacture of active pharmaceutical ingredients, intermediates and nutraceutical ingredients. Net sales by source of revenue break down into product sales (97.9%) and service sales (2.1%). At the end of March 2020, the group has 2 production sites located in India.
Employees
11,565
Date Price Change Volume
07/09/26 INR 9,315.00 +2.36% 502,162
04/09/26 INR 9,100.00 -1.62% 250,202
03/09/26 INR 9,250.00 +0.33% 497,269
02/09/26 INR 9,220.00 +0.60% 403,619
01/09/26 INR 9,165.00 -3.19% 485,620
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
9,315.00INR
Average target price
8,447.00INR
Spread / Average Target
-9.32%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DIVISLAB Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!